Treatment of extensive cutaneous metastatic melanoma with topical diphencyprone
- PMID: 17276544
- DOI: 10.1016/j.jaad.2006.12.018
Treatment of extensive cutaneous metastatic melanoma with topical diphencyprone
Abstract
Diphencyprone is a potent contact sensitizer sometimes used to treat alopecia areata and cutaneous warts. A patient with previous primary nodular melanoma on the scalp developed extensive, confluent cutaneous metastases near the primary site, unsuitable for treatment with surgery or radiotherapy. Topical treatment with diphencyprone as a single agent resulted in regression of all lesions, and the patient remains well 18 months later. Topical immunotherapy with diphencyprone was an inexpensive and well-tolerated treatment for extensive cutaneous melanoma metastases in our patient unsuitable for other therapies.
Similar articles
-
Topical diphencyprone immunotherapy for cutaneous metastatic melanoma.Australas J Dermatol. 2009 Nov;50(4):266-71. doi: 10.1111/j.1440-0960.2009.00556.x. Australas J Dermatol. 2009. PMID: 19916970
-
Topical immunotherapy with diphencyprone for in transit and cutaneously metastatic melanoma.J Surg Oncol. 2014 Mar;109(4):308-13. doi: 10.1002/jso.23506. Epub 2013 Nov 19. J Surg Oncol. 2014. PMID: 24522938 Review.
-
Topical immunotherapy with diphenylcyclopropenone in combination with DTIC and radiation for cutaneous metastases of melanoma.Dermatology. 2005;211(4):370-1. doi: 10.1159/000088512. Dermatology. 2005. PMID: 16286751 No abstract available.
-
Diphencyprone as a therapeutic option in cutaneous metastasis of melanoma. A single-institution experience.An Bras Dermatol. 2018 Mar;93(2):299-301. doi: 10.1590/abd1806-4841.20187162. An Bras Dermatol. 2018. PMID: 29723355 Free PMC article.
-
Topical immunotherapy in dermatology.Int J Clin Pract. 1999 Mar;53(2):130-7. Int J Clin Pract. 1999. PMID: 10344049 Review.
Cited by
-
Developments in Intralesional Therapy for Metastatic Melanoma.Cancer Control. 2016 Jan;23(1):12-20. doi: 10.1177/107327481602300104. Cancer Control. 2016. PMID: 27009452 Free PMC article. Review.
-
Topical and Intralesional Treatments for Skin Metastases and Locoregionally Advanced Melanoma.Cancers (Basel). 2024 Dec 29;17(1):67. doi: 10.3390/cancers17010067. Cancers (Basel). 2024. PMID: 39796696 Free PMC article. Review.
-
Effective topical treatment of subcutaneous murine B16F10-Nex2 melanoma by the antimicrobial peptide gomesin.Neoplasia. 2008 Jan;10(1):61-8. doi: 10.1593/neo.07885. Neoplasia. 2008. PMID: 18231639 Free PMC article.
-
Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy.Ann Surg Oncol. 2021 Feb;28(2):1029-1038. doi: 10.1245/s10434-020-08713-1. Epub 2020 Jun 15. Ann Surg Oncol. 2021. PMID: 32542563 Free PMC article.
-
Therapeutic vaccination immunomodulation: forming the basis of all cancer immunotherapy.Ther Adv Vaccines Immunother. 2019 Aug 1;7:2515135519862234. doi: 10.1177/2515135519862234. eCollection 2019. Ther Adv Vaccines Immunother. 2019. PMID: 31414074 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical